dihydroresveratrol has been researched along with flufenamic acid in 1 studies
Studies (dihydroresveratrol) | Trials (dihydroresveratrol) | Recent Studies (post-2010) (dihydroresveratrol) | Studies (flufenamic acid) | Trials (flufenamic acid) | Recent Studies (post-2010) (flufenamic acid) |
---|---|---|---|---|---|
35 | 2 | 27 | 1,058 | 69 | 202 |
Protein | Taxonomy | dihydroresveratrol (IC50) | flufenamic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.76 | |
Transthyretin | Homo sapiens (human) | 2.9 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.615 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.112 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4901 | |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 1.3467 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 2.64 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, S; Connelly, S; Johnson, SM; Kelly, JW; Mortenson, DE; Powers, ET; Wilson, IA | 1 |
1 other study(ies) available for dihydroresveratrol and flufenamic acid
Article | Year |
---|---|
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Topics: Amyloid Neuropathies, Familial; Computer Simulation; Drug Design; Humans; Molecular Docking Simulation; Prealbumin; Protein Multimerization; Protein Stability; Small Molecule Libraries | 2017 |